0001493152-23-021877.txt : 20230620 0001493152-23-021877.hdr.sgml : 20230620 20230620165439 ACCESSION NUMBER: 0001493152-23-021877 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230614 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hillstream BioPharma Inc. CENTRAL INDEX KEY: 0001861657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 842642541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41210 FILM NUMBER: 231025990 BUSINESS ADDRESS: STREET 1: 1200 ROUTE 22 EAST CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 302-743-2995 MAIL ADDRESS: STREET 1: 245 MAIN STREET STREET 2: SUITE 204 CITY: CHESTER STATE: NJ ZIP: 07930 8-K 1 form8-k.htm
0001861657 false 0001861657 2023-06-14 2023-06-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) June 14, 2023

 

HILLSTREAM BIOPHARMA, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41210   84-2642541

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I. R. S. Employer

Identification No.)

 

1200 Route 22 East, Suite 2000

Bridgewater, NJ 08807

(Address of principal executive offices, including zip code)

 

(908) 955-3140

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.0001 par value   HILS   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 4.01 Changes in Registrant’s Certifying Accountant.

 

On June 14, 2023, Mayer Hoffman McCann P.C. (“MHM”), the independent registered public accounting firm of Hillstream BioPharma, Inc. (the “Company”), provided the Company notice of its resignation as the Company’s independent registered public accounting firm effective as of the earlier of: (i) the date the Company appoints a new independent registered public accounting firm; (ii) the date the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 is filed with the Securities and Exchange Commission (“SEC”); and (iii) August 19, 2023.

 

MHM audited the Company’s consolidated financial statements as of and for the years ended December 31, 2022 and 2021.

 

The audit reports of MHM on the consolidated financial statements of the Company and its subsidiaries as of and for the years ended December 31, 2022 and 2021 did not contain any adverse opinion or disclaimer of opinion nor were they qualified or modified as to uncertainty, audit scope, or accounting principles except that MHM’s report on the consolidated financial statements of the Company and its subsidiaries as of and for the year ended December 31, 2022 contained an explanatory paragraph as to the Company’s ability to continue as a going concern. Furthermore, as previously reported in the Company’s Current Report on Form 8-K filed with the SEC on May 22, 2023, which disclosure is incorporated herein by reference, the Company, after discussion with its audit committee concluded that its previously issued audited financial statements for the year ended December 31, 2022 and unaudited financial statements for the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022 should be restated and no longer be relied upon. Moreover, as further described in the Company’s periodic reports filed with the SEC, during the years ended December 31, 2022 and 2021, the Company has identified material weaknesses relating to (i) vendor invoices, (ii) lack of control(s) to review the completeness and accuracy of contracts with a financial reporting implication and the timely communication of the terms and conditions to the financial reporting function; (iii) lack of segregation of duties; and (iv) the Company lacking sufficient appropriate accounting and reporting knowledge to effectively perform review controls surrounding technical accounting matters.

 

During the Company’s fiscal years ended December 31, 2022 and 2021 and the subsequent interim period through June 14, 2023 there were no disagreements between the Company and MHM on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of MHM would have caused MHM to make reference to the subject matter of the disagreements in connection with its audit reports on the Company’s financial statements. Except as set forth herein, there were no reportable events (as described under Item 304(a)(1)(v)(A)-(D) of Regulation S-K) during the Company’s fiscal years ended December 31, 2022 and 2021 and the subsequent interim period through June 14, 2023.

 

The Company provided MHM with a copy of this Current Report on Form 8-K in accordance with Item 304(a) of Regulation S-K prior to its filing with the SEC and requested that MHM furnish the Company with a letter addressed to the SEC stating whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree. A copy of the letter from MHM is filed as Exhibit 16.1 hereto.

 

The Company is committed to continue conducting a competitive selection process to determine the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
16.1   Letter of Mayer Hoffman McCann P.C. dated June 20, 2023
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

-2-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 20, 2023 Hillstream BioPharma, Inc.
   
  /s/ Randy Milby
  Randy Milby
  Chief Executive Officer

 

-3-

 

 

EX-16.1 2 ex16-1.htm

 

Exhibit 16.1

 

June 20, 2023

 

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

 

Commissioners:

 

We have read Item 4.01 of Hillstream BioPharma, Inc.’s Form 8-K dated June 20, 2023, and we agree with the statements set forth in Item 4.01, insofar as they relate to our firm. We have no basis to agree or disagree with other statements made by the registrant contained in Item 4.01. 

 

Very truly yours,

 

/s/ Mayer Hoffman McCann P.C.

 

Los Angeles, California

 

 

EX-101.SCH 3 hils-20230614.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 hils-20230614_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Information, Former Legal or Registered Name EX-101.PRE 5 hils-20230614_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Jun. 14, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 14, 2023
Entity File Number 001-41210
Entity Registrant Name HILLSTREAM BIOPHARMA, INC.
Entity Central Index Key 0001861657
Entity Tax Identification Number 84-2642541
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1200 Route 22 East
Entity Address, Address Line Two Suite 2000
Entity Address, City or Town Bridgewater
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08807
City Area Code (908)
Local Phone Number 955-3140
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, $0.0001 par value
Trading Symbol HILS
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Entity Information, Former Legal or Registered Name Not Applicable
XML 7 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001861657 2023-06-14 2023-06-14 iso4217:USD shares iso4217:USD shares 0001861657 false 8-K 2023-06-14 HILLSTREAM BIOPHARMA, INC. DE 001-41210 84-2642541 1200 Route 22 East Suite 2000 Bridgewater NJ 08807 (908) 955-3140 Not Applicable false false false false Common stock, $0.0001 par value HILS NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 25 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://hillstreambio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ex16-1.htm hils-20230614.xsd hils-20230614_lab.xml hils-20230614_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 25 }, "contextCount": 1, "dts": { "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "hils-20230614_lab.xml" ] }, "presentationLink": { "local": [ "hils-20230614_pre.xml" ] }, "schema": { "local": [ "hils-20230614.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 60, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 25, "memberCustom": 0, "memberStandard": 0, "nsprefix": "HILS", "nsuri": "http://hillstreambio.com/20230614", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-06-14to2023-06-14", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://hillstreambio.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "From2023-06-14to2023-06-14", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://hillstreambio.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001493152-23-021877-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-021877-xbrl.zip M4$L#!!0 ( -.&U%;287(/'@, !@4 * 97@Q-BTQ+FAT;>U8;6_: M,!#^'BG_X8:T?2()=&VU08K$6P=;2E&)6O6C29S$6V)3VY2R7[\+$,JF:MTJ M5K4P/N#XY<[W/'<^6^?V_#.O81INK]OL8 OYS_7[OM=MN,ZRQ5EG->VVSCO7 M,/*OO>Y)*1)'DY4(81E2PJH2"*#O]6K@X9D3'C MEA:3&N#R]#_Q-W59$,I;.:X]I7ZQ5[#M=&E-JO.-C-:F[ M3JX0T0^?;+>F=]HB*8MY#22+$_WL4-Q6HWN7L#'3IE$]MJNNTVIL =@?H'@ M_9:!%6[Z#:)-$[Y.E6;1?*EKBS#')/@62S'EH16(5,@:S!*FZ3;!?IYR:AH' ME3(<5 [>/Y?_G@'8(R=M1]PWHL%4,LVH,@W"0^C>!0GA,86VR#*F%!-\URFH M5BJF<0HC+2G5,+"[]JXCOB(J83S6@I=-HV.W;3R[1X5X;R_HQ2J6K[ MX[ZGO7+6CGXI**_PXDS(+05)20A]33,XM"M5$!'T6)HJ3$@D@Q83PX3(C)2A MSP/[G50W4U%7<"ID!A^L+Q 234/([V$HKN$RY+E\1H'$F-1@QG0".J&@-*[- M*-<*%.:Z2$B<8-PTUIN7L:M$1"00E8O,T;@4A4 +$%,)$9.9#5<4%H9S@3PI MIO+9Y59"0LC4QK8"E6BB\ M%*_O1VJZI')N&EI.TSG,,7!4>7]<^/H .:Z6(#ZKV$=*E M1,I"!.8W6UX7VEW/&S8[G?[@TTFI4EKT1\-FN^BO]ECI0VY2,E%H6O%5QXLT MU$D.LO+VH7*#?U'HN*52LX"D11"B1WZ.RI1&"XE.(;&A^IX_OY,7UB[ROQP! MMLA%0PAC'Q,9VP#F_N$;2 &,+2=;!L;_^[9Z1A 0B<;S@!"_9; #-U3U]3D_/ MZ/A_H[Y!!LQQN66^S2BY0H8P4[-T;G;?9GROD]W/_*^RN7'<\Z >U#7=MYF> MY]F'^?QP.,P-2SG+Z>:5@X.#_ CK9&2EPU%JO6*AH.2_-"_;6H_U:9:;KD=- MC46-#&X^S.\?2Z.JJF/P1%5\$@Y2RL]T#:7ZI$&\\EY>%B:J>JE5=V55+ZS* M7:M<5-Y\#PY9(VHPFE=709@!0_;EI'4YJ>ZEUY]4S7L.-=V.Y?2I!S3$GG:S MA6*VN!?K).LR+=$1_,YUK<$/^]G/EI2PGQGB)#'%8I6ZT8SK;&JZPS&A %H4 MBV%%AW7F=KN7A]*PHN]FNY3:4>4.=551,2A(]!H\R[J^;1NLSTQO;CNL(]H^ MEL+6KN-]MV50/M4*^G,L@[FI(XF2!(B:Y9N>,TZ?I: PT0!&304E4>F\<=F. M:O6X8;B>PVA?Y59.L_I8M5384\H9(=6,ZO!)\,^QQSV#58[S\A-*^\RC!#O* MLD>?#]YF:I;IP71D;\+)WBUH]I_GNR1T#W@8DX&_=A&DYOI \>$J5@>^26]Z'* M%1N2EM6GYHY\L , .+PCN%WG@["=SEW;H.-#8EHF$X5\=(ALRQR4!_&+ZSHS MA73@3ZAXY?>A+TTR_LAKH=XZXR)4ID9!Q0 D'%V;K&M$ CJ64ZL M^.?G8!K&M%YC@YXRT^IS\T?#_GA>IL=-ZS@L3\S"S(0&$AJ31ZD>0MUXG(?V M\(G_'=L_JX>/2)\Z76X>$JP:_7]$D"FSU.!=*-) H)B3J1R[-C7C(V0[M,\- MT-H_&$/4=?G?3(*4J?SW#V6O<'29&^[9Z6V\?Y]49/EHA M9-KUVL=6X[91;V]N5*].2?U+[;QZ]:Y.:M?-9J/=;EQ?K2B&Q0##S]3M<;/K M6>;.YL9IKI8CQ<)N^6!%L7H=(G1VW6H"Q*)+="UPW7)0D,N\;/;4TGSTKG$U M?*=%*\?)&O+OTK=QY[:@ZOO[X'[_8W<^/EZFLI^]F/;EHYE>L\PO,M1J!=14 MJWYUN[G1JM]GIK>YX5E03\.X)E%*Q'*(LKNE;Q.K0[P> M6V4:H6EDFN]PCS-WJO-@K@JW]P ,K28;3D> MV<('2!9&8 RP,S/-+"4 RU3>^R8C2GF'8*]K2_7[ M0!\Z-].,MAUW"MDJJWZB&I@KW!64%$XT6P0ZA+79AI& M('7"@7">2T#9@]YPME<5W709\JAJ,!C-,."Y)C:B"QGQVZ:Z'O[^:0QC$9$H MT*%9AD%M%P *O\F8X;'G/&>'06ZCZ5.AEC":HJ9'4YX&_8 Y'M>H$1+#L^P( MI5+QSQ?P,Z;UQ7Y"7S1,S7+ C(G-X[8')J F-S!KECY'?8P/1A=?SFZ4ZUII M$68*][@Q@.XQV[$&*$%)._4$.,%D,X,.P<(]1;=X^BS)GT]0R24139=/TBGA M2\/F=3/PFP0#GW&# ;55YJ1S*_/N.UW]ZW[/UQ9F["9CXHZ3DBTK1:6P9KW7 MSWKE!.O=TE$CV%W4A%[Z'A\V/^VWM+KUGE_U%L:')>N;A;5I[( ME?"/LT +^H]H#-.S*H[0EK!$$GW+(9;78PZYAV6]JW,1MDCX2&*25@4UJR,! MYG'#&_=8EZ7-?KD*^]:ZP<(\4BJ5/7F^/U[9!Y>Z+S MNB^FXW9RRCY,+./,:;W8TOI2$DW.EKY\:Q!N!WSHD_W>O.^67!O7^X51:-U=3XFV4A^%6!_CM1/50L M58?1^1+S-_VJJWN[NYJQ".,3'P]XZ:"POSU'1F9U6!A*O[3 Q;[I6>9W(Y'O M:H7;>W;5&Q?9 N">'C-3.=C=S9:4\N]B*12=:EQ[4A",X?I\_>O'?LCUZNV MVMVE"S.93X,'' ++V]RHVK8!:SA8F+U&69/XAYO9CMBK8PZATLJ"E'6(S%;2 MB8M>$C%@Q1$DPZS%[0G0W_NNQSOC18)?ZS'M 51BCQ%JVXX%;A#F+*G6B*C, ML(9(-"Q$VI+][ 7I< /U)'=!:7K,U(&8G@7T[/N&1TUF^:XQ)B[(@]L9BY9! M TL%'(28!%EX\5P'6!,AXU!S'!9V+ -&QX:XNOBX>67[:P[-S&^;$ M__Y!/#& JI K[G)SZ5P];4+. A/RV>$>,"W&KWTS"*:Y<[9_3PQS[VNA53]X M_O(JGE.G6I;!J"G.9,:M2"I(R#(';\KEH[EF8B%!WB53(4!- J@E$"1VD*J+ MR@//#)%R<5>J 2'^DQQ7D=FZI;PAM;,6 >+DH.+VHG8@%\_G2Y[2A<;X7QS6 M?Q6IYN7UMBUP 8&US6X3 U^<&ND*Z/1K46WU=+=S75RJ IJ%YW5HGPE>$L9^ M@-VLZE'*-*L48]HGD54?Z9YR(2=KKM7/*M!_K7Y20TXW#D-? V]C$&?+T(5W MKCN=><&G3Q*6NOTTY23K MKM73*O##6CVEKM"FU$##=7WF_%!):?5W5^?7WSY^U)\?(7^&DIJ![E^MJDHL M6][2GJ:J@KIS5-4Z=^6%HX#Q(Z5.%+A.T#@Z3BO,41"E [JN@W*_P5FD.2GO M]U7+V'*WUU3ZO:0)MRJ3PL1"$PZJ'Y0'/)G8AT6>!7FR!ONC5JO7S\X6 MYMLN81ZG7-MZ&/B31G:L%%6AM=)=V3<%[;[O%)J#O44DJ4V/F:F@_QIF$+N> MI3WLD/\KY/#Z0V)3APRHX<_?G%ZX]_J;9\&_+*,4 D8)=*74DNE<,CHH7GN/ M#UJUO;\ +DD,*([@M]K M4?7/GJI.@RE3N>V%AVFHJ]-'TD;-0IK4>6 >N;RL_8B=?L4J&X>H![VQN3#'/O,U3F7,7-GLG&M5D MFSE7(W6;N[?-FGHZ6.CVA>?X;#87,!6N(":X]\.8X)KU7E37=3#?;)[VPI1@ MJ0M)4A7RF=RU'B@Z9C#- T5G6B)6YKM,U (,@@PY?-4&%_$S>4DW\I08RQ@+ M]A]R&!L9WP0$H,AA ^Y"0]"?U-1PUYIJX@41""J^Z$2GCN[*W#A]7J2NM$6C M2%U<+^9^< :E/KJ-X)67?*7+5O?BR]6C[3>'?"'WN8!V[X#H.W&]T??5+,4UR]A&Q(^C@T<>M'6@HL11KH]DI_\ZE MX!+#J,:>H/HD=!X/E4^'TI-CS,; IV+EL\PUB2VE1HSBLVRPCFBAIW)9.&'A MHB-<<(07WL],B\/H0U9EH+( &EO,93 1@COE+$3\$N."R5AVLO$&PA>+;/1)Q6WT,8V>E4#G+:8C]GA3A]]Q_/H/5ODA%LW M/0KNVL[F1L/48!3L,1@I6.Q,1HM<4ZP4E*)_S#5QT27>9NDP%Z91Y!-@M"!6 M,6+@[\(+#OP4P*S30>=WP+"_P/.5=^\Z\/.0;/%M\0PON$T 1FW;XB; 1(4' M_E/3=+2YL<7G=!PA\L$7-W<:X_!N8,!9G*E1"MD/8C6 K1YE+2)7#8+TZ[60-D=8&Z8"8:[Z7>!AHAS(06!E M\.H$Y[7: 9!M$ !?YUY2R"*6@R68<->HEUA(BALS,:W'#80$N2%D0+SMV0W8 M[Y1I#(_'DI(BN*,H:L(79>'ALE\_FZ^52T1@7G!)<-!2D!QX!Q404OS'7!+H MT4A5 A.@]G9]U>4ZIX[0/T_BI,V-&58B.I=A$PP84/!BQ! ZOJ 6[(3-37%@ MT(%JKF90WA>*/"HPH60(JAE''*/V-.1UR?"X;^GR.UH6B_BPX'%P &^\$TZ( MJUDVV\'*,8T>W -A %)LI#&@G]>C'@DLJ1 L)]+@_V0"-S>>,(-S13&8+L3/ M!$!M@YKX[J\Q;N+2KD/M7H!XFF:@*C>X-\9B[(>;/C()&K^NA7, #V&VS!PY M\QT,_/=AQ;.#_=D8EY)'/,,[[-'S3!NCYCL.FL\I>R1.GX96"T![@8C"VBJ $KQ?>QBMBD)^X6<'@_W"WQ>H!+MT<2"V!L W8![?_F!J@T4/1@ M^5B@1U7F#1DS9RQOX/K@3\ESPNRFVG_0'#9*NE0=*=HZ9I[0C0C\"B%1Z%K( M#BR-Z:)"9-$F4(H[,=#[P?=O&@-YEX*8"HH7*% M%&.$>BAT>8_"ZE:C/NX. MX5-HT*W% M4K:W!MM;U>WLUJG8V6JQKF](7=?.7FS'3'H%.^T$8UC/#O+IJABT,FSA*C)ZU&"'>#0 M'9;F%MC.]4*?% $#A\SD;B^ATP)@P5WQ)G?M3!0)]H;BB6(1IO& : L5X$X< M-*J"UQ>38]P;UX5V@LJZ!5512XE6.\$&.+Z<1FH0J=AF*N9(-3:'+ 2QXUA] M@4T4T**8MM/C*O2@[.44H2T\:RU**X-70I0PK2I86.GQ%:9P;'U-NI/"Q68> M%[%:5Z1/B.0(M):N<'QUABXQK' 7$1<.%U4Q&X F ,NG;O1CD4S06D&>L1=\A[7FF9/NA!.W\9-B8@B*XS*+SPLF([ M+W->L)#;Y>:"54; ?-%]^8L_;U;(*=/WF:WXD;,%D^!4+.=L^4Z;99X7F\NK MOP)Q]&-7X@#* L_*+)1Q*.DYF#O*1LI>5LGU/*#L)0L#&?,S'^0VC%B3%POA MNVCIOX;M"N4UU_V#RU!QZT-"(K+Q&H@WE0DEI]2C!%\:1+9PO:#KP?Y&L"/2 M, U=%H_(M3 '[B$.%&2K'Y%/>/(4BO]M M.:EIKPI)Y*EFX[,9SN,1N1W; $#5H2K7C@@>PY-S?67A#!83N:5A*RS)KC-> M?TW&:SP7?&47D-\[7?12@8!VX]U5]?9CJ]Y^E2_Q^06G/UX$KYO@C%*T0841 M;NXDDV1^<)0S##XG3E_I/NZJRRTQ$:P/$G1@&)41S#'%E"#Y!G65]:C1(>I8 M;ER*+::@!H:=?1-#C]@?];V>Y0#X^@L=#OWE9OOUAS,6=(GYKCBCM+B-=%BR M'$JHIM8MBPQ4+!AH4,.3U' )W20_G&!Z^-)OA_E-UER_Z5KF][Y?;X6G%\'EJ"$A"0@QYH4ORH>T^,L>)MX/7HIW[5X M*9^S[-C*,M:3SXB6E&+1DDM\7=(Z.K* Z$CIV=&1E8I?+'6NL']R)R[>$.^,DO01[=C[T=G]I\+%\+[Z MH5?/?[@>CW;/'DKWIP?OSWG9_MKZ^MAP#L[\]WJO/QZK?YUKAOK.&-2_?3[[ M]LTI?VM\L7G[@W?;T*Y&1I\-1V\>;:_>:;@?6^_8OMIMGW660WM/6^>^>5B8V#: M%][]A[//_8/"B6Y]=M]=/18O3K_DKZWVP]OZV^?1NR[/\#4$L#!!0 ( -.&U%:G2[^L5P, ,@, 1 :&EL M^($?2328F+,9D(.50E7X2["78TT;&:J96GY>S;C7Y%E3\CUXZN(O5Q>DL?^\"/ MXPO")^J!5+Z-NM>UY\-?QQT8#L8/GX^Z9#AZ?AJ&!^W^8$RK=S<'!^'=S8F MJSET#3GM2I9+5UV[W"4*9LIFE6[!4ZXTX?X2/M SPB+XT$T7EZ!T(_0HA=(< M&L *3H%?ZHNQ:Q8,OE+)@;'"?4*B&;A'5#<155)C%4<)>%3-X<:Z$;JD::GZ M*0*U63596B)\;;4[,^R ,J:T!!)VJ;"E::'5\I'WP308@Q"XOA0RO( >B9F) M9A031GL4 @=I(ON@;:VIB/BPBV1>M81S88K;=%AFL;8HHJ9ZC>%-PQYS70H& M/TWTR Y,6VUQ8!'NN3#W@X-HT'32H94RPHE8 #W*:>(Q:R(/8=LRL4W1#!-* MPUT%+TC$"H(?_#091Q*4X24IM(TA(V:0%T@^87[,BG'FH6RD9(9\J^:;ES?* M+?10TF!U6PA-1U%[Q3F9;2"A9[:5,H7S,_IM4BN90LDA5GI+@R4[O[H;F>-< M@DA_367M C B(@*IJ:G6A2Y/0Z?:TJ\7W"#K1SG(_1X\S;)YJNMU##I"JD17VO,;==C>K&WA9](;:'8&N*0W^5W EE!E5Z>S:SE[!79QNI'C M,JM[PJ MA*4WIW@@H^JB$$Y-A6-9??MVBR-_!DT,F<"^_DT*BX_D*\XCD2ET($NE'6CI M6@DK6L9E#U>\E\/Y&S.9J[T:PAR9;;LH%K3$.$)D,J#DQ/GW)451EB@>24E1DG,QXQ'?0[T4'Y/4 MU_&G'W>;%+T0GB6,GHVFAT$"]WPB-&?]Z?U75^YCGS]GI9/+Z M^GI(V0M^9?PI.XS89EB%BQSGVZRJ[6AW5/Y1X9_2A#Z=RK]6."-('"^:G>ZR MY&PD]UON]O7XD/'U9'9T-)W\\Y?K1?1(-GB<4'G<(C+24;(66]STY.1D4I1J M:4NY6_%4[^-XHNU4-8O2I$-?S M\?'T<)?%(WWPBR/(64KNR0,JFGF:OST+E+)$DC JMSUR\F WDW(^D?$32M8X M)['/X_-* >[[P)2Y;C]$/FZY'.;=^0CQWQ?9S[(RW&>?*Q(UV+_+_8SMN6 MWWUX[<&1;++Q01&8FU25M$Q A=[*":&LNZJ=A8UZDWE:,YXN^UR M9BSJS$ATN&8ODY@DHN[93'X8RP]%L\5_?I\SL1(X7V4YQU&N:RJ:<3:RE$], M2U)YSK4OS*.>QI6*2<3$U/2_IJHI7AT7L C#: MD'&2L2V/R+MZI>X6.DJEHTTJ%'))1>CXZV+T0Z%!OVG5?SY-]K4XZ&BQ!-IN M",V7HD9+"YK%KKK99DKW>+HG-(M3N_),^-=^#1EKJFQF31AJ6N"8L1B#$1#:9$2>R+B'UMQQDYX^M8+ M14OIF@O JHF&(0N*#KLW$)!*[I>1)<V,BAB0'L@,T4$*D/"P>;B1:[. MQ3)I8&-K>I_PM&QW\5.)@T7(=#B0HB(,R3A/)-5N0_0PU%*ZI@>P:G)CR((B MQNX-9$7)4:'W#\D%C0+L6V MK*-Y%JUK0$"[)B0M85"@0.Y 6%2 9J8(\0K,OPCFPW"I*?W TK)J1Z62!0B* MZ:T/$ZGW LE\RWG#-3SCP%)G-V5[S%;W9P%=$*#TF&O=M57R!BB>9J +FB?Y MFWR>[F:[61%N:5Q;XHH-R)QFPBP/@@7 E,F DB&I0TKHI>?U70*:RX<8P>:8 M,K<$V$TV*6AJ B+!:@R@8:\MGBGU0L10PFH=PM+C^TF,X X('2Z'0($B2#4C/()TA6- M&']FM<<=YFPK!L"W.8OA%4I/E%NH!C6AB59G2$" #?$)8-8(/5#/I" FW^,I M*D"R!B_$G<>Q.%!9^<]U0LD4;+]5ZY:N#KM-IBS"@$B"W0'\E,H#_0')&'1+ M0X%F]HZFSOQ#,QL*S2QH:&8?@6;YR@*!YO@=33WV#\WQ4&B.@X;F^$/0B([W M.M;,Q<=;OF2OMH>S0:479-I6K<#L9>'ATO+6!XL,D.L9&>(3DV)A=Q1BW*>[\D6N9GE&F:M \Q2A,> M)$UCO8.+4OM$XHYE.4[_G3QWGHC;Q5[PL!JV0M)0AH>*S5X?,"H&B2 ?)]8E MKO*&AO55,J/4+7OXB33YY@ M6ZML(E= P 8U#6U%$"B MDP.]D*DE8XAN.-$0DA$1Q0O ) M74'1;UC# 2N#@*37G@F+"!A'M0BD0E 1XQ>;JRS;$OXN>"PAGA "S0,@M?0A MX@29[(5*!?ID:T&BK9@?WZ:SU3+)4]O)95OB;$X"S%4SDE$>!!N *9.%H@RQ M!S2=_67U5Z2C''?_#5MR+)/'+MXV*Y8"V:>L*E<0=%C4'%@D0: ^S)IN&&H ME"*E]9&=JF'6TARCW!4 5ENZZQN%072ZS5'KR]_H:T]#_L4N>A2F"/!"@EWF M>NBWF32'_[HF" 0ZC+5.2DHITEH?+R3LIZQU_R)@[6T1L.Y9!*Q#7 2LARX" MUMX6 7JW*D6(&)=N5VFRQD!RPDZU:R@Z+)M\6*1!H0+[ \>,*@3M8UQGM"Q2 MG,GT_'Q3[/]2?+"T$M YRVG99;-*:FD3!<%(E[-66DN5=*XF1E+MFHMMG.0D M5F8N$XIIE."T2H]HNR+>'^*,EH'F*W!Z]&$P-,QD"R<5IG,95H'[5)>N+Z6K M!S!^)6GZ,V6O=$%PQBB)U;44VYVB;KW;)V9Z;# TQ"'PZ(P,&C_) M**3#RBMA7DCZQM(MS3$OWB7GMI$)T+DE![#9),80!42*W1E 2"5&2NWG!6V5 M/:):9*G?'0(;",D=OZ[=:=IX:]NJ#8B93H/0.]QESH_]VEA%>7K%,B?R]R*2 M%_(%Y[CT!K87DKM^J;++M/DVI4T;$$*=!L'W)ZL8F2H&:Z:\I8SA<['46K.. MI\0-E?O$,2V+[=PQE20@/&R^.C+(<*2U7EA8;'":?MYF"249/!$9*K3UEAN6 MHR5#7S."\D>"+LJ?H:MG@E?U^/JED2B2+T2H53F-,;?T\KC!QE9,-^+9#?X@K@H::UQSUZ8.@::!) MDZDBK'ER700B&>DSFU$]N3V\Q&N('*^,+0:-A7%-$00CH"UH65S_K0 _N?.V MJS2)+E.&X:LL#8WCC'EM>T:RO+T@( +:KJ 4>840%4HO_?\9TR>^?3%//C0N ML[FQZ&GQB,4!O-WFF9Q!A3'X*GAGD./;"P,:8-QDZ(@("+T!-J$;#D4D*D(/ MD I&M6A/YV?9/@L@B3^_W9,'PN5[!TNRRS^+'3UUG&$,B'5]]C:X.>;)7&]@ M$!"^URUTJI>A>@5H)9\1*ZM O\E*4%&+Z]\OU_=B&L\O$7Y-UCB]Y2H;MW 9 M=^9&'QKN^F[9>QIEWCT;$AL$H!\P#-Y=J^HX0*H65%0C,S+M*X*>@ZYONA:? MQ&:]2?RUPAD16_X+4$L#!!0 ( -.&U%88F\B->0< (]9 5 :&EL M&ULS9S?<]HX$,??;^;^!Q_W3 BDUVO2Y#HI#1VF M:9,+:7MW+QUA"]!$EAA)#O#?GV0#Q6#)RXLW>4B(64G[_:PM>_7#E^^6*8^> MJ=),BJM6]^2T%5$1RX2)Z57KZZA]/>H/AZU(&R(2PJ6@5RTA6^_^^O67R/Y< M_M9N1P-&>7(1?9!Q>R@F\FWTA:3T(OI(!57$2/4V^D9XYH[( >-417V9SCDU MU'Y1-'P1_7'2?3..VFU O=^H2*3Z^C#Q"Y^[=RIB8/.RUS41>"_=?>V/6=H?:W5[[K'NRU$EK S\GJ"2G M#W02N;\V>MM69XQS;10EZ9A)%[6.L^CTI3TKK;MYV9FB$UN <6V;Z)V=ONZ^ M<@W\7C(RJ[D].S5S)URU#9H/Q:6:V\V_G 9EUS@+A9R7^_ZO,Z):QJ?3.5S)Z',DN_U MW <'HY>#L/_\R!NZ'EMG26PV-7$RICRO_X>UV3/I-.#5AL2CK;':J;+%OD^[ MD;M6<2150I5EO:F+J+@4K\-3=&W1F1-E*VK'-J+;4$^43'UTUB2DQ]%=4+:) M9FA>V_83Y\. DVDUSCT3(,\N!M!*-5A$/U =*S9W7&K EBR!?'NH?"NT-8QY M<^T\T"ES_CI7W(V7NH/A?L%3! C^#+.G"*I%BL"U$!GA#W0N50WXLB60]RM, MWE7:D##_G1%EJ.(K".D#8R#L/S!A>Q0B\7Y41&CF^$" 'UH#B;]&??#P:$1" M/II1SETR1P3H+*^R!V+_$Q.[7^<+ '_S[.[O]M8"9[]3!(C_S4O!?Z 6*0+W M5#&9V%NZ K _, 92/\>D[E&(ROM&)%#:6U-P_H,/>T\>$NH!TS'AA4<#>TR' M<5>80Y&CY)RU,E&Q_TN) D/?,88B1TE#:R0V#+R?*55R)MBK^*VAR%$2T#J1 M#3._$8:9E1O]_Y*EXY\#IV76AU90QBA)IT\4"MO-2(,P;E(CQ'??$LH8)=<, MB4/AW+=Z%.%#D=#E)[H*@3XPA9)&R3&#\E!0WRN6$K4:L;B^TSBTA<)&R2S# M E%H/Y+E,+&JV(05TX+UT+U%H.Q1TDJ07)00#$4LU5SN#!?W96:OQU5?)L$N MO:8@-!PH^>81TE&"_[EE@G9#H:@T!\\1X04@(/.%8.\=A[T'QXZ2 MA];*?"'8SX[#?@;'CI*+ULK$Q-ZW'^_4HUQX9J"]QE#D*+EHC41,X/F=YD[= M*_G,BM51==0/2D#1(Z:H8;&H)WQQDX><[1M+*&_$=+5:'";G>ZD-X?^Q>=V3 M9+4]E#EBXAH2VO0 8Q%W-VCA6TJT9P+EBY*K5LII&JF+L*+$?_J6+:! 41+0 M*C$-\[R5;NYC)D5P//;0"LH5)9/TB6JZXW6KB;7WTM_Y&KR"#:5;W9?1,,;O MBAGK05^F:2;68S2>63&/*10O2OH7E-EG^X2H&.'5G*OLH)!1 MDCV_L(8)WROJ(DWM8W>^CLMM-U!WDXFOYPW90XFCY'KU0G')#[7.J#J6?T4I M:!10TCZHZ*;[&1IGMMM;=7OC1[=CQM/+'%A!6:.D?#Y1#;/](A\5<;OV1JMT M++E_>TBE(90P2H(7D-8PY)(?U7CW3*!@43*[2CE(?<+-,IX1,:7^U0O5EE# M*)E>2!Q:WSL%];W3(_M>E(S/)PJ);;$VW%Y1=V/.IL2_DRQ8 +S/!I-X0&K3 M^_?R+3]N/[=*$RAR!'G#CWR<-9>%HN:M_>>XL4=(>*^$E#PB).(8;%(Z],, M=3ZS9_J!&++V,,3?5P+*'W%",2P6;?V\ZML;SU2&Y\SW#*&T$9?"5DI#@3Q* M">?O,\T$U<&^9<\0"AEQS6NE-!3(-RE54]NI?51R86;KO9TAV)X"4.B(*UN# M4G'@+W_N(R_VOP7)5UB#WTZ B-TK$NNU&W'L%E(4=W*1$.6A'K*'?RDAF4+V(66B$+!>][(IY4-C?QZE[)F%(W?:*W5QL@(0)6 M T)8GYZ% J8F3H!PI*<@ M_7.C%TW>KQ[HA"JW3.&1+LU[V]!3^*$(4!P:']0W"H$Q((WSE&8;J+JE4\+O M5+$-VWJ:U.TQA]8 #19BTGPZX]\C]02P$" M% ,4 " #3AM16TF%R#QX# 8% "@ @ $ 97@Q M-BTQ+FAT;5!+ 0(4 Q0 ( -.&U%:Z Z@(@A< NJ + M " 48# !F;W)M."UK+FAT;5!+ 0(4 Q0 ( -.&U%:G2[^L5P, ,@, M 1 " ?$: !H:6QS+3(P,C,P-C$T+GAS9%!+ 0(4 Q0 M ( -.&U%9R0G/P. L ">) 5 " 7<> !H:6QS+3(P M,C,P-C$T7VQA8BYX;6Q02P$"% ,4 " #3AM16&)O(C7D' "/60 %0 M @ 'B*0 :&EL&UL4$L%!@ % - 4 -@$ (XQ $! end